A5027897203- Kawasaki Disease and Coronary Complications
- Hospital Admissions and Outcomes
- Emergency and Acute Care Studies
- Mechanical Circulatory Support Devices
- Healthcare Policy and Management
- Coronary Artery Anomalies
- Streptococcal Infections and Treatments
- COVID-19 Impact on Reproduction
- Healthcare cost, quality, practices
- Healthcare Systems and Technology
- Magnesium in Health and Disease
- Autoimmune and Inflammatory Disorders Research
- Pneumonia and Respiratory Infections
- Clinical practice guidelines implementation
- Electronic Health Records Systems
- Potassium and Related Disorders
- COVID-19 Clinical Research Studies
- Cardiac, Anesthesia and Surgical Outcomes
University of Alabama at Birmingham Hospital
2015-2025
University of Alabama at Birmingham
2020-2022
Children's of Alabama
2020
Although intravenous immunoglobulin (IVIG) is effective therapy for Kawasaki disease, 10-20% of patients have recrudescent fever as a sign persistent inflammation and require additional treatment. We aimed to compare infliximab with second infusion IVIG treatment resistant disease.In this multicentre comparative effectiveness trial, (aged 4 weeks 17 years) disease at least 36 h after completion their first were recruited from 30 hospitals across the USA. Patients randomly assigned (1:1) (2...
<h3>Importance</h3> Public health measures implemented during the COVID-19 pandemic had widespread effects on population behaviors, transmission of infectious diseases, and exposures to environmental pollutants. This provided an opportunity study how these factors potentially influenced incidence Kawasaki disease (KD), a self-limited pediatric vasculitis unknown etiology. <h3>Objectives</h3> To examine change in KD across United States evaluate whether public affected prevalence KD....
Active pediatric COVID-19 pneumonia and MIS-C are two disease processes requiring rapid diagnosis different treatment protocols.
INTRODUCTION Children meeting Centers for Medicare and Medicaid Services (CMS) criteria critical care billing are often cared by pediatric hospital medicine teams outside the intensive unit (ICU). Current CMS guidance allows of codes an ICU. These have substantially higher relative value units (RVU) attached to them reimburse at rates than usual evaluation management codes. Several efforts optimize use has been described in emergency literature, though few with hospitalists.
Background and Objective: Hypomagnesemia, defined as a serum magnesium (Mg) level &lt;1.5 mg/dL (0.62 mmol/L), is often asymptomatic. The goals of this study were to determine the incidence clinically significant abnormal Mg levels in inpatient setting identify diagnoses for which testing would be diagnostically helpful. Methods: We obtained data from 2010 through 2011 on charges supplementation all non-ICU inpatients 43 tertiary care children’s hospitals Pediatric Health Information...
GUIDELINE TITLE : 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management Kawasaki Disease RELEASE DATE March 7, 2022 PRIOR VERSION (S) 2017 DEVELOPER Rheumatology and Vasculitis FUNDING SOURCE TARGET POPULATION Children with disease
OBJECTIVES Assigning patients to a call team every fourth day (bolus system) caused the maldistribution of among resident teams and required additional faculty effort for overflow patient care. We changed continuous daily rotation (drip examined effect on clinical workload teams, education, utilization. METHODS This is retrospective study based records 7 am census, attending physician schedules pediatric hospital medicine service with 5 measures including noon conference attendance, scores...
GUIDELINE TITLE : Direct Admission to the Hospital for Children in United States RELEASE DATE March 3, 2023 PRIOR VERSION(S) n/a DEVELOPER American Academy of Pediatrics, Committee on Care FUNDING SOURCE Pediatrics TARGET POPULATION who are potential candidates direct hospital admission
Dr. Hofto has no conflicts of interest, financial or otherwise, to report. Drs. Samuy and Scalici disclose grant funding as co-investigators in a Patient Centered Outcomes Research Institute-funded multi-institutional study regarding MIS-C its relationship Kawasaki Disease (PCORI Prime Award 1602-34473, Subaward #115329114); however, this did not support the design preparation manuscript.